Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

The prevalence of familial hyperaldosteronism in apparently sporadic primary aldosteronism in Germany: a single center experience.

Pallauf A, Schirpenbach C, Zwermann O, Fischer E, Morak M, Holinski-Feder E, Hofbauer L, Beuschlein F, Reincke M.

Horm Metab Res. 2012 Mar;44(3):215-20. doi: 10.1055/s-0031-1299730. Epub 2012 Jan 24.

PMID:
22274719
2.

Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms).

Mulatero P, Tizzani D, Viola A, Bertello C, Monticone S, Mengozzi G, Schiavone D, Williams TA, Einaudi S, La Grotta A, Rabbia F, Veglio F.

Hypertension. 2011 Nov;58(5):797-803. doi: 10.1161/HYPERTENSIONAHA.111.175083. Epub 2011 Aug 29.

3.

Primary aldosteronism: learning from the study of familial varieties.

Stowasser M, Gordon RD.

J Hypertens. 2000 Sep;18(9):1165-76. Review.

PMID:
10994747
4.

KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism.

Mulatero P, Tauber P, Zennaro MC, Monticone S, Lang K, Beuschlein F, Fischer E, Tizzani D, Pallauf A, Viola A, Amar L, Williams TA, Strom TM, Graf E, Bandulik S, Penton D, Plouin PF, Warth R, Allolio B, Jeunemaitre X, Veglio F, Reincke M.

Hypertension. 2012 Feb;59(2):235-40. doi: 10.1161/HYPERTENSIONAHA.111.183996. Epub 2011 Dec 27.

5.

[Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].

Szücs N, Gláz E, Varga I, Tóth M, Kiss R, Patócs A, Jakab C, Perner F, Járay J, Horányi J, Dabasi G, Molnár F, Major L, Füto L, Rácz K, Tulassay Z.

Orv Hetil. 2006 Jan 15;147(2):51-9. Hungarian.

PMID:
16509213
6.

Familial hyperaldosteronism type II: five families with a new variety of primary aldosteronism.

Stowasser M, Gordon RD, Tunny TJ, Klemm SA, Finn WL, Krek AL.

Clin Exp Pharmacol Physiol. 1992 May;19(5):319-22.

PMID:
1521363
7.

[The role of aldosterone in hypertension].

Vonend O, Quack I, Rump LC.

Wien Klin Wochenschr. 2010 Feb;122(3-4):65-74. doi: 10.1007/s00508-010-1313-5. German.

PMID:
20213371
8.

The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism.

Somlóová Z, Widimský J Jr, Rosa J, Wichterle D, Strauch B, Petrák O, Zelinka T, Vlková J, Masek M, Dvoráková J, Holaj R.

J Hum Hypertens. 2010 Oct;24(10):625-30. doi: 10.1038/jhh.2010.65. Epub 2010 Jun 24.

PMID:
20574447
9.

Familial hyperaldosteronism.

Stowasser M, Gordon RD.

J Steroid Biochem Mol Biol. 2001 Sep;78(3):215-29. Review.

PMID:
11595502
10.

Primary aldosteronism: who should be screened?

Monticone S, Viola A, Tizzani D, Crudo V, Burrello J, Galmozzi M, Veglio F, Mulatero P.

Horm Metab Res. 2012 Mar;44(3):163-9. doi: 10.1055/s-0031-1295409. Epub 2011 Nov 25. Review.

PMID:
22120135
11.

Familial varieties of primary aldosteronism.

Stowasser M, Gunasekera TG, Gordon RD.

Clin Exp Pharmacol Physiol. 2001 Dec;28(12):1087-90. Review.

PMID:
11903322
12.

Clinical, biochemical and genetic approaches to the detection of familial hyperaldosteronism type I.

Stowasser M, Bachmann AW, Jonsson JR, Tunny TJ, Klemm SA, Gordon RD.

J Hypertens. 1995 Dec;13(12 Pt 2):1610-3.

PMID:
8903619
13.

[Primary aldosteronism].

Fardella CE, Mosso LM, Carvajal CA.

Rev Med Chil. 2008 Jul;136(7):905-14. doi: /S0034-98872008000700014. Epub 2008 Sep 4. Review. Spanish.

14.

New genetic insights in familial hyperaldosteronism.

Jackson RV, Lafferty A, Torpy DJ, Stratakis C.

Ann N Y Acad Sci. 2002 Sep;970:77-88. Review.

PMID:
12381543
15.

Genetics of primary aldosteronism.

Funder JW.

Front Horm Res. 2014;43:70-8. doi: 10.1159/000360870. Epub 2014 Jun 10.

PMID:
24943299
16.

Familial hyperaldosteronism type II: description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) gene.

Torpy DJ, Gordon RD, Lin JP, Huggard PR, Taymans SE, Stowasser M, Chrousos GP, Stratakis CA.

J Clin Endocrinol Metab. 1998 Sep;83(9):3214-8.

PMID:
9745430
17.

A new presentation of the chimeric CYP11B1/CYP11B2 gene with low prevalence of primary aldosteronism and atypical gene segregation pattern.

Carvajal CA, Campino C, Martinez-Aguayo A, Tichauer JE, Bancalari R, Valdivia C, Trejo P, Aglony M, Baudrand R, Lagos CF, Mellado C, Garcia H, Fardella CE.

Hypertension. 2012 Jan;59(1):85-91. doi: 10.1161/HYPERTENSIONAHA.111.180513. Epub 2011 Nov 14.

18.

Examination of chromosome 7p22 candidate genes RBaK, PMS2 and GNA12 in familial hyperaldosteronism type II.

Jeske YW, So A, Kelemen L, Sukor N, Willys C, Bulmer B, Gordon RD, Duffy D, Stowasser M.

Clin Exp Pharmacol Physiol. 2008 Apr;35(4):380-5. doi: 10.1111/j.1440-1681.2008.04882.x.

PMID:
18307725
19.

Genetics of primary aldosteronism.

Gordon RD, Klemm SA, Tunny TJ, Stowasser M.

Clin Exp Pharmacol Physiol. 1994 Nov;21(11):915-8.

PMID:
7882585
20.

High prevalence of primary aldosteronism in the Tayside hypertension clinic population.

Lim PO, Dow E, Brennan G, Jung RT, MacDonald TM.

J Hum Hypertens. 2000 May;14(5):311-5.

PMID:
10822317
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk